Android app on Google Play

CONMED Corp. (CNMD) Altrus Thermal Tissue Fusion System Given Marketing Clearance by FDA

December 3, 2010 7:10 AM EST Send to a Friend
CONMED Corporation (NASDAQ: CNMD) announced that their Altrus Thermal Tissue Fusion System has been granted marketing clearance from the U.S. Food and Drug Administration.

The company believes that the current marketplace for energy based instruments approximates $1.5 billion.




You May Also Be Interested In


Related Categories

Corporate News, FDA

Add Your Comment